|
|
|
 |
FDA Approval Activities for this Drug…
Prograf (tacrolimus capsules ,tacrolimus injection) Fujisawa Healthcare NDA 50-708/S10 12/1/00 5/2/03 | Prograf (tacrolimus capsules ,tacrolimus injection) Fujisawa Healthcare NDA 50-708/S12 7/25/01 5/2/03 | Prograf (tacrolimus capsules ,tacrolimus injection) Fujisawa Healthcare NDA 50-708/S13 12/1/00 5/2/03 | Prograf (tacrolimus capsules, tacrolimus injection) Fujisawa Healthcare NDA 50-708/S15,S16 Protopic (Tacrolimus) Ointment, 0.03%/0.1%, Fujisawa Healthcare NDA 50-777/S4 4/18/03 | Protopic (Tacrolimus) Ointment, 0.03%/0.1%, Fujisawa Healthcare NDA 50-777 | Protopic (Tacrolimus) Ointment, Fujisawa Healthcare Prograf (tacrolimus) Capsules, Fujisawa Healthcare | Prograf (tacrolimus) Injection, Fujisawa Healthcare | PROTOPIC (tacrolimus) Ointment, Astellas Pharma, Package Change | Prograf (tacrolimus) Capsules, Astellas Pharma, Labeling Revision | Prograf (tacrolimus) Injection, Astellas Pharma, Labeling Revision | PROTOPIC (tacrolimus) Ointment, Astellas Pharma, Labeling Revision | Prograf (Tacrolimus) Capsules, Astellas Pharma, New or Modified Indication | Prograf (Tacrolimus) Injection, Astellas Pharma, New or Modified Indication | Prograf (tacrolimus) Capsules, Astellas Pharma, Labeling Revision | Prograf (tacrolimus) Injection, Astellas Pharma, Labeling Revision | Protopic (tacrolimus) Ointment, Astellas Pharma US, Inc., Manufacturing Change or Addition | Prograf (tacrolimus) Capsules, Astellas Pharma US, Inc., Labeling Revision | Prograf (tacrolimus) Injection, Astellas Pharma US, Inc., Labeling Revision | Prograf (tacrolimus) Capsules, Astellas Pharma US, Inc., Labeling Revision | Prograf (tacrolimus) Injection, Astellas Pharma US, Inc., Labeling Revision | Tacrolimus Capsules, Sandoz Inc., Approval | Tacrolimus Capsules, Dr. Reddy's Laboratories, Approval | Tacrolimus Capsules, Watson Laboratories, Inc., Approval | Tacrolimus Capsules, Mylan Pharmaceuticals, Inc., Approval | Prograf (tacrolimus) Capsules, Astellas Pharma, Labeling Revision | Prograf (tacrolimus) Injection, Astellas Pharma, Labeling Revision | Tacrolimus Capsules, Accord Healthcare, Inc., Approval
  
|